Philips Medical Systems (Cleveland) Inc recalls BrightView are gamma cameras; Designed for single or dual detector nuclear imaging.
- Recall date
- December 17, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1020-2016
- FDA classification
- Class II
- Brand / firm
- Philips Medical Systems (Cleveland) Inc
- Sold / distributed
- Worldwide Distribution-US (nationwide) including the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, VA, VT, WA, WI, WV & WY, and in DC and PR and in the countries of Algeria, A…
Why it was recalled
The firm discovered four issues with the BrightView Family systems. Issue 1: During a cardiac non-Auto Body Contouring (ABC) scan, using Cardiac High Resolution (CHR) collimators, the collimator may come in contact with the bottom edge of the patient pallet. If this occurs, collision sensors would pause the scan. Issue 2: During a scan, the gantry motion may halt prematurely. This cause
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
BrightView are gamma cameras; Designed for single or dual detector nuclear imaging.
Get recall alerts
Free email alert whenever Philips Medical Systems (Cleveland) Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Philips Medical Systems (Cleveland) Inc